🇺🇸 FDA
Patent

US 6506879

Purified Apo A and Apo E compounds and methods for using them

expired A61KA61K38/00A61P

Quick answer

US patent 6506879 (Purified Apo A and Apo E compounds and methods for using them) held by Esperion Therapeutics, Inc. expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00, A61P, A61P9/00